Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China

Quality of Life Research

Volumn 24, Issue 3, 2015, Pages 693-703

  Sun, Sun ^a,b   Chen, Jiaying ^c   Kind, Paul ^d   Xu, Ling ^e   Zhang, Yaoguang ^e   Burström, Kristina ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM COUNTY COUNCIL   (Sweden)

^c NANJING MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e BEIJING HOSPITAL   (China)

Author keywords

China; EQ 5D; Experience based values; General population; Health status; Visual analogue scale

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHINA; DISEASE SEVERITY; EQ 5D 3L HEALTH STATE; FEMALE; GENERAL HEALTH STATUS ASSESSMENT; HEALTH STATUS; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; MIXED ANXIETY AND DEPRESSION; PAIN; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SELF CARE; SENSITIVITY ANALYSIS; VISUAL ANALOG SCALE; WORK EXPERIENCE; ASIAN CONTINENTAL ANCESTRY GROUP; DEPRESSION; PAIN MEASUREMENT; PROCEDURES; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DEPRESSION; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; QUALITY OF LIFE; SELF REPORT; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84925506414     PISSN: 09629343     EISSN: 15732649     Source Type: Journal    
DOI: 10.1007/s11136-014-0793-6     Document Type: Article

References (51)

1. Rabin, R., & de Charro, F. (2001). EQ-SD: A measure of health status from the EuroQol Group. Annals of Medicine,33(5), 337–343.
2. Drummond, M. F., Sculpher, M., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005). Methods for the economic evaluation of health care programs. New York: Oxford University Press.
3. Szende, A., & Williams, A. (2004). Measuring self-reported population health: an international perspective based on EQ-5D. Hungary: SpringMed Publishing.
4. Devlin, N. J., Parkin, D., & Browne, J. (2010). Patient-reported outcome measures in the NHS: New methods for analysing and reporting EQ-5D data. Health Economics,19(8), 886–905.
5. Ting, R. Z. W., Nan, H., Yu, M. W. M., Kong, A. P. S., Ma, R. C. W., Wong, R. Y. M., et al. (2011). Diabetes-related distress and physical and psychological health in Chinese type 2 diabetic patients. Diabetes Care,34(5), 1094–1096.
6. Zhao, F. L., Yue, M., Yang, H., Wang, T., Wu, J. H., & Li, S. C. (2010). Health-related quality of life in Chinese patients with chronic prostatitis/chronic pelvic pain syndrome. Quality of Life Research,19(9), 1273–1283.
7. Wang, H., Kindig, D. A., & Mullahy, J. (2005). Variation in Chinese population health related quality of life: results from a EuroQol study in Beijing, China. Quality of Life Research,14(1), 119–132.
8. Sun, S., Chen, J., Johannesson, M., Kind, P., Xu, L., Zhang, Y., et al. (2011). Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008. Quality of Life Research,20(3), 309–320.
9. Sun, S., Chen, J., Johannesson, M., Kind, P., Xu, L., Zhang, Y., et al. (2011). Regional differences in health status in China: Population health-related quality of life results from the National Health Services Survey 2008. Health & Place,17(2), 671–680.
10. Wang, H. M., Patrick, D. L., Edwards, T. C., Skalicky, A. M., Zeng, H. Y., & Gu, W. W. (2011). Validation of the EQ-5D in a general population sample in urban China. Quality of Life Research,21(1), 155–160.
11. Szende, A., Oppe, M., & Devlin, N. (Eds.). (2007). EQ-5D value sets: Inventory, comparative review and user guide. Dordrecht: Springer.
12. Xie, F., Gaebel, K., Perampaladas, K., Doble, B., & Pullenayegum, E. (2014). Comparing EQ-5D valuation studies: A systematic review and methodological reporting checklist. Medical Decision Making,34(1), 8–20.
13. Stolk, E. A., Oppe, M., Scalone, L., & Krabbe, P. F. (2010). Discrete choice modeling for the quantification of health states: The case of the EQ-5D. Value in Health,13(8), 1005–1013.
14. Dolan, P., & Kahneman, D. (2008). Interpretations of utility and their implications for the valuation of health. The Economic Journal,118(525), 215–234.
15. De Wit, G. A., Busschbach, J. J. V., & De Charro, F. T. (2000). Sensitivity and perspective in the valuation of health status: Whose values count? Health Economics,9(2), 109–126.
16. Burström, K., Sun, S., Gerdtham, U.-G., Henriksson, M., Johannesson, M., Levin, L.-Å., et al. (2014). Swedish experience-based value sets for EQ-5D health states. Quality of Life Research,23(2), 431–442.
17. Gandjour, A. (2010). Theoretical foundation of patient v. population preferences in calculating QALYs. Medical Decision Making,30(4), E57–E63.
18. Burström, K., Johannesson, M., & Diderichsen, F. (2006). A comparison of individual and social time trade-off values for health states in the general population. Health Policy,76(3), 359–370.
19. Dolan, P. (2011). Thinking about it: Thoughts about health and valuing QALYs. Health Economics,20(12), 1407–1416.
20. Kind, P. (2009). Valuing EQ-5D health states—A VASly simpler solution? In J. J. V. Busschbach, R. Rabin, & F. de Charro (Eds.), 24th Scientific plenary meeting of the EuroQol Group, Kijkduin-The Hague, the Netherlands, September 13–15, 2007: proceedings. Rotterdam: EuroQol Group Executive Office.
21. Leidl, R., & Reitmeir, P. (2011). A value set for the EQ-5D based on experienced health states. PharmacoEconomics,29(6), 521–534.
22. Rand-Hendriksen, K., Augestad, L. A., Kristiansen, I. S., & Stavem, K. (2011). Comparison of hypothetical and experienced EQ-5D valuations: relative weights of the five dimensions. Quality of Life Research,21(6), 1005–1012.
23. Brazier, J., Akehurst, R., Brennan, A., Dolan, P., Claxton, K., McCabe, C., et al. (2005). Should patients have a greater role in valuing health states? Applied Health Economics and Health Policy,4(4), 201–208.
24. Dolan, P. (2008). Developing methods that really do value the ‘Q’ in the QALY. Health Economics, Policy and Law,3, 69–77.
25. Mann, R., Brazier, J., & Tsuchiya, A. (2009). A comparison of patient and general population weightings of EQ-5D dimensions. Health Economics,18(3), 363–372.
26. Ubel, P. A., Loewenstein, G., & Jepson, C. (2003). Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Quality of Life Research,12(6), 599–607.
27. Polsky, D., Willke, R. J., Scott, K., Schulman, K. A., & Glick, H. A. (2001). A comparison of scoring weights for EuroQol derived from patients and the general public. Health Economics,10(1), 27–37.
28. Zethraeus, N., & Johannesson, M. (1999). A comparison of patient and social tariff values derived from the time trade-off method. Health Economics,8(6), 541–545.
29. Badia, X., Herdman, M., Dipstat, M. R., & Ohinmaa, A. (2001). Feasibility and Validity of the VAS and TTO for eliciting general population values for temporary health states: A comparative study. Health Services and Outcomes Research Methodology,2(1), 51–65.
30. National Bureau of Statistics of China. (2009). China Statistical Yearbook 2008. Retrieved 23 March 2014, from http://www.stats.gov.cn/tjsj/ndsj/2008/indexeh.htm.
31. SAS Institute Inc. (2010). Base SAS 9. 2 procedures guide: Statistical procedures (3rd ed.). Cary, NC: SAS Institute.
32. Greiner, W., Weijnen, T., Nieuwenhuizen, M., Oppe, S., Badia, X., Busschbach, J., et al. (2003). A single European currency for EQ-5D health states. The European Journal of Health Economics,4(3), 222–231.
33. Hilbe, J. M. (2007). Negative binomial regression. Cambridge, New York: Cambridge University Press.
34. Tobin, J. (1958). Estimation of relationships for limited dependent variables. Econometrica,26(1), 24–36.
35. Gutenbrunner, C., & Jureckova, J. (1992). Regression rank scores and regression quantiles. The Annals of Statistics,20(1), 305–330.
36. Williams, A. (1995). The measurement and valuation of health: A chronicle (Discussion paper No. 136) (p. 13). York: Centre for Health Economics, University of York. http://www.york.ac.uk/che/pdf/DP136.pdf.
37. Greiner, W., Claes, C., Busschbach, J. J. V., & Schulenburg, J. M. (2005). Validating the EQ-5D with time trade off for the German population. European Journal of Health Economics,6(2), 124–130.
38. Lamers, L. M., McDonnell, J., Stalmeier, P. F. M., Krabbe, P. F. M., & Busschbach, J. J. V. (2006). The Dutch tariff: Results and arguments for an effective design for national EQ-5D valuation studies. Health Economics,15(10), 1121–1132.
39. Tongsiri, S., & Cairns, J. (2011). Estimating population-based values for EQ-5D health states in Thailand. Value in Health,14(8), 1142–1145.
40. Jo, M. W., Kim, S.-H., Minsu, O., & Lee, S. (2013). Exploratory study for dimensions of health related quality of life in South Korea. Presented at the 29th scientific plenary meeting of the EuroQol Group, Montreal, Canada.
41. Luo, N., Liu, G., Li, M., Jin, X., & Guan, H. (2013). Estimating the time trade-off values of the EQ-5D-5L health states in urban China. Presented at the 29th scientific plenary meeting of the EuroQol Group, Montreal, Canada.
42. Shaw, J. W., Johnson, J. A., Chen, S., Levin, J. R., & Coons, S. J. (2007). Racial/ethnic differences in preferences for the EQ-5D health states: results from the U.S. valuation study. Journal of Clinical Epidemiology,60(5), 479–490.
43. Leung, B., Luo, N., So, L., & Quan, H. (2007). Comparing three measures of health status (perceived health with Likert-type scale, EQ-5D, and number of chronic conditions) in Chinese and white Canadians. Medical Care,45(7), 610–617.
44. Oishi, S. (2010). Culture and well-Being: Conceptual and methodological issues. In E. Diener, D. Kahneman, & J. F. Helliwell (Eds.), International differences in well-being. Oxford Scholarship Online. http://www.oxfordscholarship.com/view/10.1093/acprof:oso/9780199732739.001.0001/acprof-9780199732739-chapter-3#acprof-9780199732739-bibItem-93.
45. Luo, N., Li, M., Chevalier, J., Lloyd, A., & Herdman, M. (2012). A comparison of the scaling properties of the English, Spanish, French, and Chinese EQ-5D descriptive systems. Quality of Life Research,22, 2237–2243.
46. Cleemput, I., Kind, P., & Kesteloot, K. (2004). Re-scaling social preference data: implications for modelling. European Journal of Health Economics,5(4), 290–298.
47. Md Yusof, F. A., Goh, A., & Azmi, S. (2012). Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods. Value in Health,15(1), S85–S90.
48. Parkin, D., & Devlin, N. (2006). Is there a case for using visual analogue scale valuations in cost-utility analysis? Health Economics,15(7), 653–664.
49. Naylor, C., & Llewellyn-Thomas, H. (1998). Utilities and preferences for health states: time for a pragmatic approach? Journal of Health Services Research & Policy,3(3), 129–131.
50. Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Medical Care,43(3), 203–220.
51. Dolan, P. (1997). Modeling valuations for Euroqol health states. Medical Care,35(11), 1095–1108.